Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 26534
Event :Antigen- Specific Immune Tolerance Drug Development Summit

Dates :Tuesday April 24th, 2018 - Thursday April 26th, 2018

Location :The Aloft Boston Seaport
401-403 D St
02210 Boston, United States

Type :Conference & Seminar - International audience

Accreditation :--


Further information


As the first generation of antigen-specific immune tolerance therapies enter clinics and with excitement around recent partnerships, IPOs and investments reaching new heights, now is the time for an industry forum for large pharma, pioneering biotech and academia to be able to meet and share knowledge.
The 1st Antigen-Specific Immune Tolerance Drug Development Summit is that forum, and has a brand-new agenda that can help you successfully overcome the scientific, product development and commercialization challenges currently being faced.
Conference + 2 Workshops Earlybird (Book by 26/01/18): USD 3197
Conference + 2 Workshops (standard rate): USD 3797
Conference + 1 Workshop Earlybird (Book by 26/01/18): USD 2798
Conference + 1 Workshop (standard rate): USD 3398
Conference Earlybird (Book by 26/01/18): USD 2199
Conference (Standard rate): USD 2799
Speakers: Amy S. Rosenberg (CDER/FDA), Arpita Maiti (Pfizer, Inc.), Lachy McLean (Takeda Pharmaceuticals), Jose M. Carballido (Novartis), Jack A. Ragheb (Eli Lilly & Co), Lawrence A. Steinman (Tolerion), Laurence A. Turka (Immune Tolerance Network), Matthias von Herrath (Novo Nordisk), Kei Kishimoto (Selecta Biosciences), Jonathan Zalevsky (Nektar Therapeutics), Francisco J. Quintana (AnTolRx)
Time: on Tuesday April 24, 2018 at 8:00 am (ends Thursday April 26, 2018 at 5:00 pm)


Map and directions
Conference address :
The Aloft Boston Seaport
401-403 D St
02210 Boston
United States
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama


Antigen- Specific Immune Tolerance Drug Development Summit Medicine - Pharmacy
antigen-specific autoimmunity, insulin-specific b cells, biomarkers, biomarkers for type 1 diabetes, antigen-specific, antigen-specific tolerance, antigen-specific tolerance for type 1 diabetes, antigens
-- -- --


For more information on Antigen- Specific Immune Tolerance Drug Development Summit, plsase contactr Hanson Wade

To obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama

Recommend this event